| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Blastic Natural Killer Cell Leukemia/Lymphoma Presenting as Overt Leukemia
|
Álvarez-Larrán, Alberto
|
|
2001
|
2 |
3 |
p. 178-182
5 p.
|
artikel
|
| 2 |
Commentary on “Blastic Natural Killer Cell Leukemia/Lymphoma Presenting as Overt Leukemia”
|
Jones, Dan
|
|
2001
|
2 |
3 |
p. 183-184
2 p.
|
artikel
|
| 3 |
Current Understanding of Possible Mechanisms of Action and Resistance of Rituximab
|
Fisher, Maxine D.
|
|
2001
|
2 |
3 |
p. 145-147
3 p.
|
artikel
|
| 4 |
Diffuse Large-Cell Lymphomas: A Review of Therapy
|
Godwin, John E.
|
|
2001
|
2 |
3 |
p. 155-163
9 p.
|
artikel
|
| 5 |
Durable Remission in Recurrent T-Cell—Rich B-Cell Lymphoma with the Anti-CD20 Antibody Rituximab
|
Natkunam, Yasodha
|
|
2001
|
2 |
3 |
p. 185-187
3 p.
|
artikel
|
| 6 |
Editorial
|
Jain, Vinay K.
|
|
2001
|
2 |
3 |
p. 138-
1 p.
|
artikel
|
| 7 |
Feasibility and Safety of Outpatient Bexxar® Therapy (Tositumomab and Iodine I 131 Tositumomab) for Non-Hodgkin's Lymphoma Based on Radiation Doses to Family Members
|
Rutar, Frank J.
|
|
2001
|
2 |
3 |
p. 164-172
9 p.
|
artikel
|
| 8 |
Hematological Malignancies and Pregnancy: A Final Report of 84 Children Who Received Chemotherapy In Utero
|
Avilés, Agustin
|
|
2001
|
2 |
3 |
p. 173-177
5 p.
|
artikel
|
| 9 |
Highlights From: 43rd Annual Meeting of the American Society of Hematology December 7–11, 2001 Orlando, Florida: First International Congress on Monoclonal Antibodies in Cancer August 30-September 2, 2001 Banff, Alberta, Canada
|
D'Orazio, Amy I.
|
|
2001
|
2 |
3 |
p. 139-144
6 p.
|
artikel
|
| 10 |
Monoclonal Antibodies in the Prehybridoma Era: A Brief Historical Perspective and Personal Reminiscence
|
Stone, Marvin J.
|
|
2001
|
2 |
3 |
p. 148-154
7 p.
|
artikel
|
| 11 |
Phase II Trial of Remitogen™ (Humanized 1D10) Monoclonal Antibody Targeting Class II in Patients with Relapsed Low-Grade or Follicular Lymphoma
|
Brown, Kevin S.
|
|
2001
|
2 |
3 |
p. 188-190
3 p.
|
artikel
|
Tijdschrift beschrijving